X

Amphastar Pharmaceuticals Inc (AMPH) Amphastar Announces FDA Approval for Ipratropium Bromide HFA

Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) FY 2026 Other Release

Newsdesk: